CYLD anticorps (AA 500-600)
-
- Antigène Voir toutes CYLD Anticorps
- CYLD (Cylindromatosis (Turban Tumor Syndrome) (CYLD))
-
Épitope
- AA 500-600
-
Reactivité
- Humain, Souris, Boeuf (Vache), Singe, Primate
-
Hôte
- Lapin
-
Clonalité
- Polyclonal
-
Conjugué
- Cet anticorp CYLD est non-conjugé
-
Application
- Western Blotting (WB)
- Fonction
- Rabbit polyclonal antibody raised against synthetic peptide of CYLD.
- Réactivité croisée
- Boeuf (Vache), Humain, Singe, Souris, Primate
- Immunogène
- A synthetic peptide corresponding to amino acids 500-600 of human CYLD.
- Top Product
- Discover our top product CYLD Anticorps primaire
-
-
- Indications d'application
-
Western Blot (2 mg/mL)
The optimal working dilution should be determined by the end user. - Restrictions
- For Research Use only
-
- Format
- Liquid
- Buffer
- In Tris-citrate/phosphate buffer, pH 7.0-8.0 (0.09 % sodium azide)
- Agent conservateur
- Sodium azide
- Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Stock
- 4 °C
- Stockage commentaire
- Store at 4°C. Do not freeze.
-
-
Reduced expression of CYLD in human colon and hepatocellular carcinomas." dans: Carcinogenesis, Vol. 28, Issue 1, pp. 21-7, (2006) (PubMed).
: "
-
Reduced expression of CYLD in human colon and hepatocellular carcinomas." dans: Carcinogenesis, Vol. 28, Issue 1, pp. 21-7, (2006) (PubMed).
-
- Antigène
- CYLD (Cylindromatosis (Turban Tumor Syndrome) (CYLD))
- Autre désignation
- CYLD (CYLD Produits)
- Synonymes
- anticorps BRSS, anticorps CDMT, anticorps CYLD1, anticorps CYLDI, anticorps EAC, anticorps MFT, anticorps MFT1, anticorps SBS, anticorps TEM, anticorps USPL2, anticorps 2010013M14Rik, anticorps 2900009M21Rik, anticorps C130039D01Rik, anticorps mKIAA0849, anticorps cyld, anticorps LRRGT00003, anticorps Rp1, anticorps Rp1h, anticorps CYLD lysine 63 deubiquitinase, anticorps cylindromatosis (turban tumor syndrome), a, anticorps CYLD, anticorps Cyld, anticorps cylda
- ID gène
- 1540
- Pathways
- Apoptose, Activation of Innate immune Response
-